Literature DB >> 20930564

Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells.

Monique Provansal1, Stéphane Roche, Manuela Pastore, Danielle Casanova, Maxime Belondrade, Sandrine Alais, Pascal Leblanc, Otto Windl, Sylvain Lehmann.   

Abstract

Neurodegenerative diseases are often associated with misfolding and deposition of specific proteins in the nervous system. The prion protein, which is associated with transmissible spongiform encephalopathies (TSEs), is one of them. The normal function of the cellular form of the prion protein (PrP(C)) is mediated through specific signal transduction pathways and is linked to resistance to oxidative stress, neuronal outgrowth and cell survival. In TSEs, PrP(C) is converted into an abnormally folded isoform, called PrP(Sc), that may impair the normal function of the protein and/or generate toxic aggregates. To investigate these molecular events we performed a two-dimensional gel electrophoresis comparison of neuroblastoma N2a cells expressing different amounts of PrP(C) and eventually infected with the 22L prion strain. Mass spectrometry and peptide mass fingerprint analysis identified a series of proteins with modified expression. They included the chaperones Grp78/BiP, protein disulfide-isomerase A6, Grp75 and Hsp60 which had an opposite expression upon PrPC expression and PrP(Sc) production. The detection of these proteins was coherent with the idea that protein misfolding plays an important role in TSEs. Other proteins, such as calreticulin, tubulin, vimentin or the laminin receptor had their expression modified in infected cells, which was reminiscent of previous results. Altogether our data provide molecular information linking PrP expression and misfolding, which could be the basis of further therapeutic and pathophysiological research in this field.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20930564      PMCID: PMC3268962          DOI: 10.4161/pri.4.4.13435

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  49 in total

1.  Gene expression profile following stable expression of the cellular prion protein.

Authors:  Jun-ichi Satoh; Takashi Yamamura
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

2.  Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis.

Authors:  Mark Kristiansen; Marcus J Messenger; Peter-Christian Klöhn; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge; Sarah J Tabrizi
Journal:  J Biol Chem       Date:  2005-09-12       Impact factor: 5.157

3.  Cell line dependent RNA expression profiles of prion-infected mouse neuronal cells.

Authors:  Alex D Greenwood; Marion Horsch; Anna Stengel; Ina Vorberg; Gloria Lutzny; Elke Maas; Sandra Schädler; Volker Erfle; Johannes Beckers; Hermann Schätzl; Christine Leib-Mösch
Journal:  J Mol Biol       Date:  2005-04-12       Impact factor: 5.469

4.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

Review 5.  Prion protein biology.

Authors:  S B Prusiner; M R Scott; S J DeArmond; F E Cohen
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

6.  Construction and characterization of murine neuroblastoma cell clones allowing inducible and high expression of the prion protein.

Authors:  O Windl; H Lorenz; C Behrens; A R Mer; H A Kretzschmar
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

7.  Direct interaction between prion protein and tubulin.

Authors:  Krzysztof Nieznanski; Hanna Nieznanska; Krzysztof J Skowronek; Katarzyna M Osiecka; Dariusz Stepkowski
Journal:  Biochem Biophys Res Commun       Date:  2005-08-26       Impact factor: 3.575

8.  The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity.

Authors:  Claudio Hetz; Milene Russelakis-Carneiro; Sébastien Wälchli; Sonia Carboni; Elisabeth Vial-Knecht; Kinsey Maundrell; Joaquín Castilla; Claudio Soto
Journal:  J Neurosci       Date:  2005-03-16       Impact factor: 6.167

9.  Prion protein PrPc interacts with molecular chaperones of the Hsp60 family.

Authors:  F Edenhofer; R Rieger; M Famulok; W Wendler; S Weiss; E L Winnacker
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

10.  The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells.

Authors:  R Rieger; F Edenhofer; C I Lasmézas; S Weiss
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

View more
  6 in total

Review 1.  Application of "Omics" Technologies for Diagnosis and Pathogenesis of Neurological Infections.

Authors:  Farshid Noorbakhsh; Atefeh Aminian; Christopher Power
Journal:  Curr Neurol Neurosci Rep       Date:  2015-09       Impact factor: 5.081

Review 2.  Extracellular vesicles with diagnostic and therapeutic potential for prion diseases.

Authors:  Arun Khadka; Jereme G Spiers; Lesley Cheng; Andrew F Hill
Journal:  Cell Tissue Res       Date:  2022-04-08       Impact factor: 5.249

3.  Proteomics analysis of amyloid and nonamyloid prion disease phenotypes reveals both common and divergent mechanisms of neuropathogenesis.

Authors:  Roger A Moore; Dan E Sturdevant; Bruce Chesebro; Suzette A Priola
Journal:  J Proteome Res       Date:  2014-08-29       Impact factor: 4.466

4.  Cellular prion protein mediates early apoptotic proteome alternation and phospho-modification in human neuroblastoma cells.

Authors:  Saima Zafar; Christina Behrens; Hassan Dihazi; Matthias Schmitz; Inga Zerr; Walter J Schulz-Schaeffer; Sanja Ramljak; Abdul R Asif
Journal:  Cell Death Dis       Date:  2017-01-19       Impact factor: 8.469

Review 5.  Physiological Functions of the Cellular Prion Protein.

Authors:  Andrew R Castle; Andrew C Gill
Journal:  Front Mol Biosci       Date:  2017-04-06

Review 6.  The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases.

Authors:  Wioletta Rozpędek-Kamińska; Natalia Siwecka; Adam Wawrzynkiewicz; Radosław Wojtczak; Dariusz Pytel; J Alan Diehl; Ireneusz Majsterek
Journal:  Int J Mol Sci       Date:  2020-03-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.